AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Crypto investors who missed out on the early stages of memecoins like Memecoin (MEME) now have another chance to capitalize on a promising new meme coin, BTFD Coin (BTFD).
BTFD Coin, a meme coin built on Ethereum, is gaining traction in the crypto market with its unique blend of humor, community power, and real utility. Its presale has already raised over $5.97 million and sold over 69 billion coins to more than 10,400 investors, indicating strong bullish sentiment.
The 14th stage of BTFD's presale is currently underway, offering tokens at just $0.00016 each. Analysts predict a whopping 275% return on investment (ROI) when BTFD hits $0.0006 at listing. This presents an attractive opportunity for early investors to make significant gains.
BTFD Coin sets itself apart from other meme coins by offering tangible value through its live Play-to-Earn (P2E) game and high-yield staking options. The P2E game, launched on January 1, 2025, allows holders to earn BTFD tokens by navigating through multiple levels and completing challenges. This not only adds fun and engagement but also creates a full-fledged earning opportunity within the BTFD ecosystem.
In addition to the P2E game, BTFD offers a 90% APY staking feature, enabling holders to generate passive income. By staking 100,000 BTFD today, investors could see their holdings grow to 190,000 BTFD in a year, thanks to compounding.
BTFD's presale has been a resounding success, with over $5.97 million raised and 69 billion tokens already sold. The current price of $0.00016 is a steal compared to its listing price of $0.0006, offering a potential 275% ROI just from the presale alone. For instance, investing $25,500 in BTFD now could result in approximately 159,375,000 BTFD tokens, which would be worth around $95,62

Quickly understand the history and background of various well-known coins

Dec.02 2025

Dec.02 2025

Dec.02 2025

Dec.02 2025

Dec.02 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet